advisorsecurities master

DCOYDecoy Therapeutics Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
14065
Ticker
DCOY
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2015-01-29
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
DCOY

Detail

Enriched 2026-08-14 20:47

Market cap
$1,915,084.8
Shares outstanding (class)
590,185
Shares outstanding (weighted)
531,968
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
11
Location
HOUSTON, TX
Description

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data